We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) closed at $239.53 in the latest trading session, marking a +0.51% move from the prior day. The stock lagged the S&P 500's daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.62%, and the technology-dominated Nasdaq saw an increase of 1.07%.
Shares of the provider of cloud-based software services for the life sciences industry have appreciated by 9.8% over the course of the past month, outperforming the Medical sector's gain of 2.77% and lagging the S&P 500's gain of 11.33%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's earnings report is expected on May 28, 2025. The company is predicted to post an EPS of $1.74, indicating a 16% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $727.99 million, showing a 11.94% escalation compared to the year-ago quarter.
VEEV's full-year Zacks Consensus Estimates are calling for earnings of $7.30 per share and revenue of $3.05 billion. These results would represent year-over-year changes of +10.61% and +10.99%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Veeva Systems. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.06% decrease. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
From a valuation perspective, Veeva Systems is currently exchanging hands at a Forward P/E ratio of 32.65. For comparison, its industry has an average Forward P/E of 23.47, which means Veeva Systems is trading at a premium to the group.
Meanwhile, VEEV's PEG ratio is currently 1.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 2.63.
The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 77, which puts it in the top 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know
Veeva Systems (VEEV - Free Report) closed at $239.53 in the latest trading session, marking a +0.51% move from the prior day. The stock lagged the S&P 500's daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.62%, and the technology-dominated Nasdaq saw an increase of 1.07%.
Shares of the provider of cloud-based software services for the life sciences industry have appreciated by 9.8% over the course of the past month, outperforming the Medical sector's gain of 2.77% and lagging the S&P 500's gain of 11.33%.
The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's earnings report is expected on May 28, 2025. The company is predicted to post an EPS of $1.74, indicating a 16% growth compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $727.99 million, showing a 11.94% escalation compared to the year-ago quarter.
VEEV's full-year Zacks Consensus Estimates are calling for earnings of $7.30 per share and revenue of $3.05 billion. These results would represent year-over-year changes of +10.61% and +10.99%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Veeva Systems. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.06% decrease. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
From a valuation perspective, Veeva Systems is currently exchanging hands at a Forward P/E ratio of 32.65. For comparison, its industry has an average Forward P/E of 23.47, which means Veeva Systems is trading at a premium to the group.
Meanwhile, VEEV's PEG ratio is currently 1.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical Info Systems industry was having an average PEG ratio of 2.63.
The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 77, which puts it in the top 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.